The much-anticipated era of disease-modifying therapy for Alzheimer’s disease has at last dawned, promising significant changes in how the condition is perceived and managed.
Guide yourself through this transition with our carefully designed independent medical education program, led by world renowned experts and covering the biggest international conferences and disclosures across 2024.
This program is available in English, French, Spanish, Italian, German, Japanese and Simplified Chinese. Select your preferred language in the menu above.
Join the journey to a new era for Alzheimer’s disease.
Led by Program Director, Professor Charlotte Teunissen, this program is designed for your individual needs and learning preferences, follow the learning path and pick up the latest news, views, and insights from our experts, with take-away resources and reflective quizzes.
A wide range of topics will be covered including advances in diagnostic tools, applicability of new and emerging biomarkers, and the latest data and experience with novel disease-modifying therapies.
We will take you on a journey from AD/PD in Lisbon, to CONy in London, followed by AAIC in Philadelphia and finally, CTAD in Madrid. You can also earn valuable Continuing Medical Education (CME) points along the way.
We know your time is precious so we have mapped a journey that enables you to access what you need when you need it.
Do you have any questions or comments for our experts? Go to the question hub, open throughout 2024.
Start your journey
JUST PUBLISHED – Coverage from ADPD
As we progress through the year, different areas of the course will become available to you with the question hub will beopen at all times. Earn badges as you engage with the content along the journey. Click on the different icons to access the multimedia content.
AD/PD™️ 2024
Lisbon, Portugal
March 5 – 9, 2024
AD/PD™️ focuses on basic science and translational and clinical research in Alzheimer’s disease and Parkinson’s disease, bringing key advances in disease mechanisms, innovative therapies, and diagnostic biomarkers.
World Congress on Controversies in Neurology (CONy)
London, England
March 21-23, 2024
CONy focuses on commonly debated topics and controversial issues faced by clinicians in neurology, helping them to understand the discrepancies between opposing points of view. In 2024, Alzheimer’s is one of the key topics.
Available March 24, 2024
Alzheimer’s Association International Conference
Philadelphia, USA
July 28 – Aug. 1, 2024
AAIC is the largest international conference on dementia research, providing a forum to share breaking research discoveries in prevention and treatment and improvement in diagnosis for Alzheimer’s disease.
Available July 29, 2024
Clinical Trials on Alzheimer’s Disease Conference
Madrid, Spain
October 29 – November 1, 2024
CTAD is a conference entirely focused on therapeutic trials in Alzheimer’s disease, featuring leaders in the Alzheimer’s field from both research and academia with the aim of progressing effective treatments.
Available October 30, 2024Meet the experts
Professor Charlotte Teunissen
Professor of Neurochemistry,
Chair of Neurochemistry lab
Amsterdam UMC, The Netherlands
Professor Oskar Hansson
Professor of Neurology,
Senior Consultant in Neurology
Lund University, Sweden
Dr Robert Perneczky
Professor of Translational Dementia Research
Director of the Division of Mental Health in Older Adults, Germany
Professor Dorota Religa
Professor of Geriatrics, Department of Neurobiology, Care Science and Society, Deputy Head of Clinical Geriatrics, Karolinska Institute, Sweden
